THOMAS A ALBERICO MD NPI 1922001064

NPI Details

Thomas A Alberico, MD is a hematology and oncology internal medicine in Norfolk, VA with 46 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Thomas A Alberico, MD NPI is 1922001064. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1979

The provider's business location address is:

5900 LAKE WRIGHT DR
NORFOLK, VA
ZIP 23502-871
Phone: (757) 466-8683
Fax: (757) 466-8892

The NPI 1922001064 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, octreotide, depot form for intramuscular injection, 1 mg (HCPCS:J2353)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Injection, doxorubicin hydrochloride, 10 mg (HCPCS:J9000)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Unclassified drugs (HCPCS:J3490)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Vitamin d-3 level (HCPCS:82306)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Urinalysis, manual test (HCPCS:81002)
• Folic acid level, serum (HCPCS:82746)
• Magnesium level (HCPCS:83735)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Vincristine sulfate, 1 mg (HCPCS:J9370)
• Uric acid level, blood (HCPCS:84550)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Drawing of blood for a medical problem (HCPCS:99195)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Injection of drug or substance into vein (HCPCS:96374)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Phosphate level (HCPCS:84100)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Refilling and maintenance of portable pump (HCPCS:96521)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)

The enumeration date for this NPI number is 5/23/2005 and was last updated on 1/17/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.